Roche's legacy of innovation includes transforming next-generation sequencing and its applications. By simplifying workflows and expanding assay menus, we are broadening access to genomic data. We aim to make next-generation sequencing routine and develop a complete sequencing solution from “Sample In” to “Result Out”.
Novel technologies for handling and storage of samples prior to nucleic acid testing
Isolation, enrichment and amplification technologies for nucleic acid testing
New platforms for automated sample prep
New platforms and reagents for improved nucleic acid testing
New technologies to measure nucleic acid modifications
Pioneering new fields/ applications for Next Generation Sequencing
For molecular diagnostics Roche develops and produces innovative tests based on the Nobel Prize-winning discovery of the polymerase chain reaction (PCR). The tests developed for oncology, virology, Human papilloma virus (HPV), microbiology and for screening blood products are used around the world by researchers, doctors, patients, hospitals, laboratories and blood banks. A new generation of tests supports healthcare providers in choosing medications based on molecular characteristics of diseases and in monitoring treatments.
If you have an opportunity for collaboration or an interesting technology, or if you have an asset in one of our areas of interest, we would like to hear from you.